Cas:42303-42-4 1-Aminocyclopropane-1-carboxylic acid ethyl ester hydrochloride manufacturer & supplier

Chemical Name:1-Aminocyclopropane-1-carboxylic acid ethyl ester hydrochloride

CAS.NO:42303-42-4

Synonyms:1-Aminocyclopropyl carboxylic acid ethyl ester hydrochloride;1-Aminocyclopropanecarboxylic Acid Ethyl Ester Hydrochloride;Cyclopropanecarboxylic acid, 1-amino-, methyl ester, hydrochloride (1:1);ACPC-OEt HCl;1-aminocyclopropane-1-carboxylic acid methyl ester hydrochloride;Methyl-1-aminocyclopropancarboxylathydrochlorid(1:1);1-Amino-Cyclopropyl-1-Carboxylic Acid Ethyl Ester Hydrochloride;Methyl 1-aminocyclopropanecarboxylate hydrochloride (1:1);Ethyl 1-Aminocyclopropanecarboxylate Hydrochloride;1-Aminocyclopropane-1-carboxylic acid ethyl ester hydrochloride;ethyl 1-aminocyclopropane-1-carboxylate,hydrochloride

Molecular Formula:C₅H₁₀ClNO₂

Molecular Weight:151.591

HS Code:29224999

Physical and Chemical Properties:

Melting point:gt. 110.0 and le 118.0 °C

Boiling point:159.7ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:52.32000

Exact Mass:151.040009

LogP:1.15300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 1-Aminocyclopropyl carboxylic acid ethyl ester hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 1-aminocyclopropane-1-carboxylate,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclopropanecarboxylic acid, 1-amino-, methyl ester, hydrochloride (1:1) Use and application,1-aminocyclopropane-1-carboxylic acid methyl ester hydrochloride technical grade,usp/ep/jp grade.

Related News: The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. rel-ethyl (1R,2R,3S)-2-benzoyl-3-(4-chlorophenyl)cyclopropane-1-carboxylate manufacturers Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). 1-{(3R,5R)-2-benzyl-3-[(1R)-1-(tert-butoxycarbonylamino)-2-hydroxyethyl]isoxazolidin-5-yl}uracil suppliers TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, (S)-2-{[3-bromo-1-(tert-butyl-dimethylsilyl)-1H-indol-4-yl]-methylamino}-3-methyl-butyric acid benzyl ester vendor & factory.